Records containing: Postherpetic Neuralgia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-08-31Phase 1 Novel Topical Treatment for Post-herpetic Neuralgia
-
CLINICAL_TRIALS study record update · 2011-08-23A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Multicenter, Parallel Group Study to Evaluate the Safety and Analgesic Activity of ATx08-001 When Administered to Subjects With Postherpetic Neuralgia
-
CLINICAL_TRIALS study record update · 2011-05-30ClinicalTrials.gov study NCT00168441
-
CLINICAL_TRIALS study record update · 2011-04-14Placebo-Controlled Study of Pregabalin for the Pain of Acute Herpes Zoster
-
CLINICAL_TRIALS study record update · 2011-03-23An Enriched Enrollment, Double-Blind, Placebo-Controlled, Parallel Group, Randomized Withdrawal Trial to Evaluate the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Moderate to Severe Neuropathic Pain
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2009-09-11A Randomized, Double-Blind, Placebo Controlled, Two-Way Cross-Over Study of Analgesic Efficacy of Bupivacaine Transdermal Therapeutic System in Patients With Post-Herpetic Neuralgia
-
CLINICAL_TRIALS study record update · 2009-09-09An Open-Label Study Of The Use Of Topical Lidocaine (2.5%)/Prilocaine (2.5%) Cream As Pre-Treatment For NGX-4010 In Subjects With Postherpetic Neuralgia (PHN)
-
CLINICAL_TRIALS study record update · 2009-07-30A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study Evaluating the Efficacy and Tolerability of Oral SLC022 300 mg TID, a Glial Cell Modulating Agent, Versus Placebo in the Treatment of Post Herpetic Neuralgia
-
CLINICAL_TRIALS study record update · 2008-10-07Phase 2/3 Multi-Center, Double-Blind, Controlled Trial Comparing Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir, and Combination Topical ARYS-01 Cream /Oral Valaciclovir for Treatment of Herpes Zoster in Immunocompetent Patients 18 Years of Age or Older
-
CLINICAL_TRIALS study record update · 2008-07-22ClinicalTrials.gov study NCT00576108